Literature DB >> 891566

Radiochemical quality control of 99mTc-labeled radiopharmaceuticals. Some daily practice guideliens.

E K Pauwels, R I Feitsma.   

Abstract

Recognizing the fact that each nuclear medicine facility should be able to perform simple radiochemical quality tests on currently used radiopharmaceuticals, this study was undertaken to evaluate a number of radiochromatographic methods. No single ideal method exists to assess the radiochemical composition of 99mTc-labeled antimony sulphur colloid, sulphur colloid, iron ascorbate, citrate, human serum albumin, EHDP, macroaggregates, and microspheres. It is advisable to include thin layer chromatography with both NaCl and methylethylethylketone for the determination of free pertechnetate in each day's program. More detailed radiochemical analysis can be performed by combining these methods with paper chromatography, paper electrophoresis, and gel filtration. It seems reasonable to regard a constant radiochromatographic pattern as a measure for constant radiochemical quality. The four chromatographic tests lead to consistent results regarding the percentage of free pertechnetate in the radiopharmaceutical preparations. Quantitative analysis shows that the radiochemical purity for each radiopharmaceutical is unique for the chromatographic method used and needs to be defined when stated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891566     DOI: 10.1007/bf00253680

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  7 in total

1.  Radiochemical purity of various 99mTc-labelled bone-scanning agents.

Authors:  O W Krogsgaard
Journal:  Eur J Nucl Med       Date:  1976

2.  Rapid determination of oxidation state of unbound 99mTc and labeling yield in 99mTc-labeled radiopharmaceuticals.

Authors:  L G Colombetti; S Moerlien; G C Patel; S M Pinsky
Journal:  J Nucl Med       Date:  1976-09       Impact factor: 10.057

3.  Chromatographic quality control of 99mTc-labeled compounds.

Authors:  M W Billinghurst
Journal:  J Nucl Med       Date:  1973-11       Impact factor: 10.057

4.  A possible artifact in gel chromatography of some 99m Tc-chelates.

Authors:  P E Valk; C A Dilts; J McRae
Journal:  J Nucl Med       Date:  1973-04       Impact factor: 10.057

5.  Analytical pitfalls with 99m Tc-labeled compounds.

Authors:  W C Eckelman; P Richards
Journal:  J Nucl Med       Date:  1972-03       Impact factor: 10.057

6.  Chemical state of 99mTc in biomedical products.

Authors:  W Eckelman; G Meinken; P Richards
Journal:  J Nucl Med       Date:  1971-09       Impact factor: 10.057

7.  Guidelines for evaluation of drugs for use in man. Report of a WHO scientific group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1975
  7 in total
  4 in total

1.  On the nature of technetium compounds. 1. A semiquantitative biological model system to assay 99mTc-complexes/radiopharmaceuticals.

Authors:  O P Noronha; K S Venkateswarlu
Journal:  Eur J Nucl Med       Date:  1981-03

2.  Composition of 99mTc-HIDA as a function of time after kit preparation.

Authors:  E K Pauwels; R I Feitsma; P Vermey
Journal:  Eur J Nucl Med       Date:  1981

3.  99mTc-gentamicin: chemical and biological evaluation.

Authors:  K Ozker; I Urgancioğlu
Journal:  Eur J Nucl Med       Date:  1981-04

4.  Determination of radiochemical purity and stability of 99mTc-diethyl HIDA.

Authors:  V Jovanović; D Konstantinovska; T Memedović
Journal:  Eur J Nucl Med       Date:  1981
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.